InMode Ltd (INMD): Market Cap to Revenue

Symbol and logo of brand InMode Ltd (INMD)

The P/S ratio dynamics for InMode Ltd. (INMD) reflect the current market trend, where the parameter value equals 2.00. The high prestige of Israeli minimally invasive systems ensures physician loyalty. Meanwhile, the implementation of ESG standards minimizes waste during device assembly. However, geopolitical tensions and logistics disruptions limit the expansion of high-tech equipment into foreign markets, creating risks for expansion rates.

INMD InMode Ltd P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for InMode Corp (INMD)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:INMD inmodemd.com
Core merchandise of InMode Ltd.

The P/S multiple relates current market capitalization to annual sales volume, allowing for the determination of the premium paid per unit of revenue. By analyzing the price-to-sales multiple, an investor assesses the monetization efficiency of InMode Ltd. medical technologies, which directly depends on consumer demand for aesthetic surgery and the successful implementation of equipment into physicians' clinical practice.

Competitors of InMode Ltd.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|Picard Medical Corp (PMI) - Price-to-Revenue Coefficient|P/S Multiple SRDX|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack, Inc.|Market Cap to Revenue Ratio NAOV (nanovibronix.com)|Price-to-Revenue Ratio Venus Concept Corp (VERO)|Market Cap to Revenue Nuwellis Corp NUWE|Price-to-Revenue Ratio Aethlon Medical AEMD|Asensus Surgical Inc (ASXC) - Price to Sales|Avinger - P/S Multiple|BSGM (BioSig) - Market Cap to Revenue Ratio|CUTR: P/S Multiple|Price to Sales Know Labs Corporation (KNW)|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|Price-to-Revenue Ratio SILK (Silk Road Medical, Inc.)